Dr. Reddy's Laboratories Files Form 6-K

Ticker: RDY · Form: 6-K · Filed: Jul 29, 2024 · CIK: 1135951

Sentiment: neutral

Topics: sec-filing, 6-K, foreign-private-issuer

TL;DR

DRL filed a 6-K on 7/29, standard foreign issuer report.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 29, 2024, to report information as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, Telangana, India, and its principal executive office is located at 8-2-337, Road No. 3, Banjara Hills.

Why It Matters

This filing indicates that Dr. Reddy's Laboratories is providing updated information to the SEC, which is important for investors to stay informed about the company's regulatory compliance and disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information that would typically increase risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to submit information that the registrant has made or is required to make public in its home country, or has filed or will file with a stock exchange on which its securities are traded.

When was this Form 6-K filed?

This Form 6-K was filed on July 29, 2024.

What is the company's central index key (CIK)?

The company's central index key (CIK) is 0001135951.

Where is Dr. Reddy's Laboratories Ltd. headquartered?

Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, Telangana, India, with its principal executive office at 8-2-337, Road No. 3, Banjara Hills.

Does Dr. Reddy's Laboratories file an annual report under Form 20-F or 40-F?

Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.7 · Accepted 2024-07-29 06:21:23

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: July 27, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing